UASt regulatory sequences drive expression of the full-length ACOX1 open reading frame (ORF) (from the GH07485 cDNA clone), mutated to carry a N250S amino acid substitution. This change is equivalent to a N237S change in the human ACOX1 gene, a variant identified in patients with progressive ataxia and hearing loss. The endogenous stop codon is present, thus even though three copies of the Tag:HA tag are present downstream of the ORF, they are not expected to form part of the translated protein. The ORF is flanked by a pair of incompatible FRT sites (FRT5 and FRT2), which allows for future in vivo exchange of either the promoter or tag sequence.
A17762864G
N250S | ACOX1-PA
N250S
Analogous N237S mutation in human ACOX1 implicated in Mitchell syndrome; mutation carried on in vitro construct.
Expression of ACOX1N250S.UAS under the control of Scer\GAL4da.G32 leads to abnormal multi-lamella bodies, aberrant membrane structures and a decrease in the number of axons in wing nerves when compared to controls. Also many axons are irregular in shape and most of the wrapping glia are aberrant in size and shape.
Expression of ACOX1N250S.UAS under the control of Scer\GAL4egr-GAL4 leads to climbing defects when compared to control adults.
Acox1N250S.UAS, Scer\GAL4da.G32 has short lived phenotype, suppressible by CatUAS.cAa, Scer\GAL4da.G32
Acox1N250S.UAS, Scer\GAL4egr-GAL4 has short lived phenotype, suppressible by CatUAS.cAa, Scer\GAL4egr-GAL4
Acox1N250S.UAS, Scer\GAL4egr-GAL4 has abnormal locomotor behavior | adult stage phenotype, suppressible by CatUAS.cAa, Scer\GAL4egr-GAL4